In the first issue of each month The Pharmaceutical Journal updates the guidance on the legal status of medicines published in the 23rd edition of ‘Medicines, ethics and practice: A guide for pharmacists', which was published in January.
The amendments are given in bold type on the first occasion they are printed in the list; thereafter they are repeated each month in light type. The legal status of a product can be obtained by consulting first the latest list of amendments and then the guide.
The abbreviations used in the list are those used in the guide and explained in the key to annotations in the body of the guide (pp21 and 61).
Actal pastils PO
Aromasin tablets POM
Artelac eye-drops P
Cardicor tablets POM
Charcodote suspension P
Clivarine injection POM
Felicium capsules POM
Femoston-conti tablets POM
Insuman insulins POM
Konakion tablets entry should read: Konakion tablets POM
Levonelle-2 tablets POM
Lysovir capsules POM
Micardis tablets POM
Norditropin Simplex POM
Normosang infusion POM
Oxycontin tablets CD POM (amended entry)
Oxynorm preparations CD POM (amended entry)
Pralenal tablets POM
Remicade infusion POM
Renagel capsules POM
Sonata capsules POM
Teveten tablets POM
Tobi nebuliser solution POM
Tixycolds cold and allergy nasal drops GSL
Tixycolds cold and hayfever inhalant capsules GSL
Tixycolds syrup P
Tixylix baby syrup GSL
Trileptal tablets POM